Takami Sato is an Oncology physician affiliated with Thomas Jefferson University. OpenAlex indexes 397 publications with 6,495 citations (h-index 44); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
925 Chestnut St
Suite 320a
Philadelphia, PA 191074216
Telephone
215-955-8874Registry record last updated 5 Jun 2014.
Clinical trials
- Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
Sponsor: Thomas Jefferson University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tempus AI, IncProgram year20251 payment
- Iovance Biotherapeutics, Inc.Program year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2004–2005 per NIH RePORTER. The latest:
- Immunoembolization of the Hepatic Artery with (GM-CSF)
Thomas Jefferson University
FY2005$289,665R21CA103250 - Immunoembolization of the Hepatic Artery with (GM-CSF)
Thomas Jefferson University
FY2004$289,665R21CA103250
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase I study of safety, tolerability, and efficacy of tebentafusp using a step-up dosing regimen and expansion in patients with metastatic uveal melanoma
Digital Commons@Becker (Washington University School of Medicine)
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Shields, MD
Thomas Jefferson University
Joseph Bavaria, MD
Thomas Jefferson University
Michele Meltzer, MD
Thomas Jefferson University
Marinos Dalakas, MD
Thomas Jefferson University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”